NCT02095184 2026-04-15
GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients
University of Maryland, Baltimore
Phase NA Terminated
University of Maryland, Baltimore
Eastern Cooperative Oncology Group
Hubei Cancer Hospital
Albert Einstein College of Medicine
Tianjin Medical University Cancer Institute and Hospital
Columbia University
University of Washington
University of Washington
West-Ward Pharmaceutical
West-Ward Pharmaceutical
Roswell Park Cancer Institute
Federal University of São Paulo
Instituto Nacional de Cancerologia de Mexico